Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marj P Zimmerman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Health & Drug Benefits|December 25, 2015
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?Marj P Zimmerman
American Health & Drug Benefits|December 25, 2015
Reviewing the Unmet Needs of Patients with Multiple SclerosisStanton R Mehr, Marj P Zimmerman
American Health & Drug Benefits|May 4, 2017
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?Stanton R Mehr, Marj P Zimmerman
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Health & Drug Benefits|December 25, 2015
How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?Marj P Zimmerman
American Health & Drug Benefits|December 25, 2015
Reviewing the Unmet Needs of Patients with Multiple SclerosisStanton R Mehr, Marj P Zimmerman
American Health & Drug Benefits|May 4, 2017
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?Stanton R Mehr, Marj P Zimmerman
Pageof 1